Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01812629 · ClinicalTrials.gov registry record · NA

Nutritional Management of Children With Chronic Diarrhea

A NA study, sponsored by Abbott Nutrition.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT01812629: Completed NA study, sponsored by Abbott Nutrition.

NCT01812629 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01812629, a NA study, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The study objective is to assess the growth, tolerance and efficacy of a complete amino acid-based medical food in children with chronic diarrhea.

Primary Outcome

Outcome dependent on individual subject assessment and may include decreased stool number, decreased vomiting, decreased gas, weight gain, increased caloric intake, increased protein intake, increased serum albumin concentration, increased hemoglobin concentration, better acceptance of supplemental formula.

Interventions

  • OTHER Experimental Infant Formula

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 1997-07
Est. Completion 1999-06
Phase NA
Abbott Nutrition

89 total trials

What the finished NCT01812629 record still lists

NCT01812629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Experimental Infant Formula is the first listed.

NCT01812629 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01812629 about?

NCT01812629 is a clinical study titled "Nutritional Management of Children With Chronic Diarrhea". The study objective is to assess the growth, tolerance and efficacy of a complete amino acid-based medical food in children with chronic diarrhea.

What is the current status of trial NCT01812629?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 1997-07. Estimated completion is 1999-06.

What interventions are being tested in trial NCT01812629?

The interventions under investigation include: Experimental Infant Formula (OTHER).

Who is sponsoring clinical trial NCT01812629?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01812629's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01812629, the US trial registry maintained by the National Library of Medicine. NCT01812629 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.